AFFY Affymax Inc.

USD 0.00 0.00 0
Icon

Affymax Inc. (AFFY) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0007

0.00 (0.00)%

USD 2.61M

500.00

N/A

N/A

Icon

AFFY

Affymax Inc. (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.61M

N/A

USD 0.00

Affymax Inc. (AFFY) Stock Forecast

N/A

Based on the Affymax Inc. stock forecast from 0 analysts, the average analyst target price for Affymax Inc. is not available over the next 12 months. Affymax Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Affymax Inc. is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Affymax Inc.’s stock price was USD 0.0007. Affymax Inc.’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -82.93% over the last year.

No recent analyst target price found for Affymax Inc.
No recent average analyst rating found for Affymax Inc.

Company Overview Affymax Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

https://www.affymax.com

630 Fifth Avenue, New York, NY, United States, 10020

2

December

USD

USA

Adjusted Closing Price for Affymax Inc. (AFFY)

Loading...

Unadjusted Closing Price for Affymax Inc. (AFFY)

Loading...

Share Trading Volume for Affymax Inc. Shares

Loading...

Compare Performance of Affymax Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AFFY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Affymax Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S -3.30 (-2.60%) USD564.56B 46.25 4.92

ETFs Containing AFFY

Symbol Name AFFY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Affymax Inc. (AFFY) Stock

Stock Target Advisor's fundamental analysis for Affymax Inc.'s stock is Bearish.

Unfortunately we do not have enough data on AFFY's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AFFY's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on AFFY's stock to indicate if its overvalued.

The last closing price of AFFY's stock was USD 0.00.

The most recent market capitalization for AFFY is USD 2.61M.

Unfortunately we do not have enough analyst data on AFFY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Affymax Inc.'s stock.

As per our most recent records Affymax Inc. has 2 Employees.

Affymax Inc.'s registered address is 630 Fifth Avenue, New York, NY, United States, 10020. You can get more information about it from Affymax Inc.'s website at https://www.affymax.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...